References
Agrawal, S., Goel, A. D., & Gupta, N. (2020). Emerging prophylaxis strategies against COVID-19. Monaldi Arch Chest Dis, 90 (1). doi:10.4081/monaldi.2020.1289
Assistant, R. (2020). COVID-19, imaging findings. Rediology Assistant .
Chiba, S. (2020). Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19. Wien Klin Wochenschr , 1-6. doi:10.1007/s00508-020-01780-0
Devaux, C. A., Rolain, J. M., Colson, P., & Raoult, D. (2020). New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents, 55 (5), 105938. doi:10.1016/j.ijantimicag.2020.105938
Ding, D., Zhu, C., & Yao, W. (2020). A Cured Patient With 2019-nCoV Pneumonia. Am J Med, 133 (11), 1291-1292. doi:10.1016/j.amjmed.2020.02.023
Fang, Y., Zhang, H., Xie, J., Lin, M., Ying, L., Pang, P., & Ji, W. (2020). Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.Radiology, 296 (2), E115-e117. doi:10.1148/radiol.2020200432
Formiga, R. O., Amaral, F. C., Souza, C. F., Mendes, D., Wanderley, C. W. S., Lorenzini, C. B., . . . Spiller, F. (2020). Neuraminidase inhibitors rewire neutrophil function in murine sepsis and COVID-19 patient cells. bioRxiv . doi:10.1101/2020.11.12.379115
Gautret, P., Lagier, J. C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., . . . Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents, 56 (1), 105949. doi:10.1016/j.ijantimicag.2020.105949
Guastalegname, M., & Vallone, A. (2020). Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? Clin Infect Dis, 71 (15), 888-889. doi:10.1093/cid/ciaa321
Iranian Ministry of Health and Medical Education . (25 march 2020). national guidelines for novel corona virus: fifth version
Iranian Ministry of health and Medical Education . (28 Feb 2020). national guidelines for novel corona virus: first version
Iranian Ministry of health and Medical Education . (deceber 2020). national guidlines for novel corona virus: 9th version
Ishaqui, A. A., Khan, A. H., Sulaiman, S. A. S., Alsultan, M. T., Khan, I., & Naqvi, A. A. (2020). Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief. Expert Rev Respir Med, 14 (5), 533-541. doi:10.1080/17476348.2020.1730180
Jiang, Y., He, S., Zhang, C., Wang, X., Chen, X., Jin, Y., . . . Lv, D. (2020). Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China. Ann Transl Med, 8 (8), 547. doi:10.21037/atm.2020.04.20
Kakeya, H., Seki, M., Izumikawa, K., Kosai, K., Morinaga, Y., Kurihara, S., . . . Kohno, S. (2014). Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study. PLoS One, 9 (3), e91293. doi:10.1371/journal.pone.0091293
Kivrak, A., Ulaş, B., & Kivrak, H. (2021). A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2. Int Immunopharmacol, 90 , 107232. doi:10.1016/j.intimp.2020.107232
Kupferschmidt, K., & Cohen, J. (2020). Race to find COVID-19 treatments accelerates. Science, 367 (6485), 1412-1413. doi:10.1126/science.367.6485.1412
Lam, S., Lombardi, A., & Ouanounou, A. (2020). COVID-19: A review of the proposed pharmacological treatments. Eur J Pharmacol, 886 , 173451. doi:10.1016/j.ejphar.2020.173451
Liu, J., Zhang, S., Wu, Z., Shang, Y., Dong, X., Li, G., . . . Chen, D. (2020). Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensive Care, 10 (1), 99. doi:10.1186/s13613-020-00706-3
Louchet, M., Sibiude, J., Peytavin, G., Picone, O., Tréluyer, J. M., & Mandelbrot, L. (2020). Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.Am J Obstet Gynecol MFM, 2 (3), 100159. doi:10.1016/j.ajogmf.2020.100159
Mosquera, R. A., De Jesus-Rojas, W., Stark, J. M., Yadav, A., Jon, C. K., Atkins, C. L., . . . Colasurdo, G. N. (2018). Role of prophylactic azithromycin to reduce airway inflammation and mortality in a RSV mouse infection model. Pediatr Pulmonol, 53 (5), 567-574. doi:10.1002/ppul.23956
physicians, r. c. o. (2017, 2017). National Early Warning Score (NEWS) 2. NEWS2 is the latest version of the National Early Warning Score (NEWS), first produced in 2012 and updated in December 2017, which advocates a system to standardise the assessment and response to acute illness. Retrieved from https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. Jama, 323 (18), 1824-1836. doi:10.1001/jama.2020.6019
Tan, Q., Duan, L., Ma, Y., Wu, F., Huang, Q., Mao, K., . . . Jin, Y. (2020). Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Bioorg Chem, 104 , 104257. doi:10.1016/j.bioorg.2020.104257
Ungogo, M. A., Mohammed, M., Umar, B. N., Bala, A. A., & Khalid, G. M. (2021). Review of pharmacologic and immunologic agents in the management of COVID-19. Biosaf Health . doi:10.1016/j.bsheal.2021.01.001
Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R., Chou, P. J., . . . Kong, A. N. (2020). An Update on Current Therapeutic Drugs Treating COVID-19. Curr Pharmacol Rep , 1-15. doi:10.1007/s40495-020-00216-7
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., . . . Liu, D. (2020). In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 71 (15), 732-739. doi:10.1093/cid/ciaa237
Yousefi, H., Mashouri, L., Okpechi, S. C., Alahari, N., & Alahari, S. K. (2021). Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Biochem Pharmacol, 183 , 114296. doi:10.1016/j.bcp.2020.114296
Zhou, L., Wang, J., Liu, G., Lu, Q., Dong, R., Tian, G., . . . Peng, L. (2020). Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method. Genomics, 112 (6), 4427-4434. doi:10.1016/j.ygeno.2020.07.044
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., . . . Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019.N Engl J Med, 382 (8), 727-733. doi:10.1056/NEJMoa2001017
Table1-patient demographic data and characteristic for two groups